Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

Laird Bloom, Edward R. LaVallie, Liqin Liu et al.|Antibodies|2016

Cited by 94